CVR: 42443670
Secondary names: Patentselskabet af 31. maj 2021 ApS
Previous names: Patentselskabet af 31. maj 2021 ApS.
Epoqe Pharma ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2021. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Patentselskabet af 31. maj 2021 ApS.. The management consists of Mark Stephen Sumeray. The company's owners include LUNDBECKFOND INVEST A/S, Helms & Sams ApS and CMCGreenhouse ApS. In 2025, the company reported a gross profit of DKK -13,719,778 and a net result of DKK -13,943,884 compared with DKK -135,919 the year before. Equity amounted to DKK 30,042,156.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udvikle og markedsføre et eller flere lægemidler, herunder at drive forskning med henblik på at identificere, validere, udvikle og markedsføre lægemidler tillige med anden virksomhed, der står i forbindelse hermed.
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.052 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (June 23, 2026).
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (June 22, 2026).
As of June 22, 2026, Mark Stephen Sumeray has joined the board of directors of Epoqe Pharma ApS.
As of June 22, 2026, Anette Sams Nielsen has left the board of directors of Epoqe Pharma ApS.
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (June 9, 2026).
As of June 2, 2026, Mark Stephen Sumeray is registered as adm. dir. of Epoqe Pharma ApS.
As of June 2, 2026, Anette Sams Nielsen has stepped down as adm. dir. of Epoqe Pharma ApS.
Contact info changed: new phone: 26343323, new website: www.epoqepharma.com (April 28, 2026).
Epoqe Pharma ApS has published its interim report for the period July 1, 2025 – December 31, 2025.
As of November 21, 2025, LUNDBECKFOND INVEST A/S is registered as an owner of Epoqe Pharma ApS with an ownership share of 20%.
As of November 21, 2025, Helms & Sams ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 10%.
As of November 21, 2025, CMCGreenhouse ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 5%.
As of November 21, 2025, is registered as an owner of Epoqe Pharma ApS with an ownership share of 33%.
Epoqe Pharma ApS has published its annual report for 2025. Gross profit came to DKK -13,719,778, and the net result was DKK -13,943,884.
As of July 31, 2025, Jens Thostrup Bukrinski has stepped down as director of Epoqe Pharma ApS.
As of January 9, 2025, Anders Gaarsdal Holst has joined the board of directors of Epoqe Pharma ApS.
As of January 9, 2025, Henrijette Elsebeth Richter has joined the board of directors of Epoqe Pharma ApS.
As of January 9, 2025, Lars Gredsted has joined the board of directors of Epoqe Pharma ApS.
As of January 8, 2025, Anders Gaarsdal Holst has left the board of directors of Epoqe Pharma ApS.
As of January 8, 2025, Henrijette Elsebeth Richter has left the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Henrijette Elsebeth Richter has joined the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Anette Sams Nielsen has joined the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Jan Bjerrum Bach has left the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Alejandra Maria Cristina Bonifacini Mørk has left the board of directors of Epoqe Pharma ApS.
As of September 19, 2024, Edvince ApS is registered as an owner of Epoqe Pharma ApS with an ownership share of 5%.
Epoqe Pharma ApS has published its annual report for 2024. Gross profit came to DKK 1,273,171, and the net result was DKK -135,919.
Epoqe Pharma ApS has published its annual report for 2023. Gross profit came to DKK -19,351, and the net result was DKK -15,427.
As of October 12, 2023, Anders Gaarsdal Holst has joined the board of directors of Epoqe Pharma ApS.
As of October 12, 2023, Jan Bjerrum Bach has joined the board of directors of Epoqe Pharma ApS.
As of October 12, 2023, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Epoqe Pharma ApS.
Epoqe Pharma ApS has published its annual report for 2022. Gross profit came to DKK -17,070, and the net result was DKK -18,026.
As of December 14, 2021, PKF Munkebo Eriksen Funch, Statsautoriseret Revisionsaktieselskab has been appointed auditor of Epoqe Pharma ApS.
As of December 14, 2021, Anette Sams Nielsen is registered as adm. dir. of Epoqe Pharma ApS.
As of December 14, 2021, Jens Thostrup Bukrinski is registered as director of Epoqe Pharma ApS.
On December 14, 2021, the company changed its name from Patentselskabet af 31. maj 2021 ApS. to Epoqe Pharma ApS.
As of December 13, 2021, Anette Sams Nielsen has stepped down as director of Epoqe Pharma ApS.
As of June 4, 2021, Anette Sams Nielsen is registered as director of Epoqe Pharma ApS.
Epoqe Pharma ApS was founded on June 4, 2021.
Companies in the same industry and area
CVR 40766383
CVR 46613139
CVR 34688605
CVR 44504332
CVR 43917897
companydata.dk